Dr. Sylvia van den Hurk is the Program Manager of Viral Pathogenesis & Vaccine Development program at VIDO-InterVac. She received her MSc at the University of Wageningen in the Netherlands and PhD at University of Saskatchewan.  Her research interests include molecular pathogenesis of bovine herpes virus-1 (BHV-1), respiratory syncytial virus (RSV) and hepatitis C virus (HCV), and the development of novel DNA, protein and dendritic cell vaccine formulations, in particular for RSV and HCV.  Dr. van den Hurk has published more than 150 peer-reviewed manuscripts, reviews and book chapters, and 8 patents with 1 pending. She has mentored more than 30 graduate students and post-doctoral fellows.  At the university she is Professor in the Department of Microbiology and Immunology in the College of Medicine.

DNA vaccines Bovine herpesvirus-1 (BHV-1) Respiratory syncytial virus (RSV) Hepatitis C virus (HCV)